Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now. As of the close of business on December 17, Wall Street analysts have a consensus Strong Buy rating on the ...

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli Lilly’s partnership with Walmart to launch retail pickup for its ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs’ top healthcare stock picks. On June 25, the company confirmed it had inked a strategic partnership with Adial Pharmaceuticals ...

* THERMO FISHER - AGREEMENT WITH AGIOS CALLS FOR IDENTIFYING IDH GENE MUTATIONS USING ONCOMINE PRECISION ASSAY AND ION TORRENT GENEXUS SYSTEM * THERMO FISHER SCIENTIFIC INC - WILL RETAIN RIGHTS TO ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Good morning, ...

SAN MATEO, Calif. and SINGAPORE, Jan. 03, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (APRTF) (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative ...

Thermo Fisher Scientific Inc., has announced a cooperation agreement with Agere Pharmaceuticals Inc., which will enable customers to accelerate formulation development of pharmaceutical compounds. The ...

* Thermo Fisher Scientific Co will retain rights to commercialize test globally and will lead necessary filings to seek clearance from regional regulatory agencies * Says under terms of agreement, ...